在患有严重血友病A的患者中,因子VIII基因重组
A C Goodeve1, F E Preston, I R Peake
1Department of Medicine and Pharmacology, Royal Hallamshire Hospital, Sheffield, UK.
Lancet (London, England)
|February 5, 1994
概括
在许多家庭中,因子VIII基因的重组会导致严重的血友病A. 检测这些遗传变化有助于预测血友病患者的抑制剂的发展.
科学领域:
- 遗传学 是一个遗传学.
- 血液学 血液学 血液学
- 分子生物学分子生物学
背景情况:
- 因子VIII (FVIII) 基因的重组是严重血友病A的重要原因,影响近50%的患者.
- 这些重新排列涉及X染色体长臂尖端的染色体内交换,在FVIII 内22内的断点.
研究的目的:
- 为了调查FVIII基因内22重组在患有严重血友病A.家族的流行率.
- 评估这些重组的存在与FVIII抑制剂的发展之间的相关性.
主要方法:
- 南方斑点分析被用来检测FVIII基因内22重组.
- 这项研究分析了23个患有严重血友病A的无亲属家庭,其中包括22名受影响的患者.
主要成果:
- 在23个无关家族中的11个中,FVIII基因内部22个重组被确定.
- 10名基因重组患者中没有一个患有FVIII抑制剂,而12名基因重组患者中只有7名患有FVIII抑制剂.
结论:
- 南方斑点检测FVIII基因内22重组是严重血友病A的宝贵诊断工具.
- 在因特龙22重组的患者中没有FVIII抑制剂,这表明潜在的保护作用或不同的疾病机制.
相关概念视频
Alternative RNA Splicing
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Extrinsic and Intrinsic Pathways of Hemostasis
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...


